Carsten Boess
Director/Miembro de la Junta en ROCKET PHARMACEUTICALS, INC. .
Fortuna: - $ al 31/05/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Karl Peggs | M | 57 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 8 años |
| Troy Wilson | M | 55 | 12 años | |
| Barry Quart | M | 67 | 12 años | |
| Iraj Ali | M | 48 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 años |
| David Southwell | M | 63 | 10 años | |
| Edwin Moses | M | 69 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 años |
| Eben Tessari | M | 42 | 10 años | |
| Lars Fruergaard Jorgensen | M | 58 | 33 años | |
| Stephen Biggar | M | 53 | 13 años | |
| Michael Giordano | M | 66 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 6 años |
| Gaurav D. Shah | M | 49 | 6 años | |
| John Militello | M | 50 | 6 años | |
| Eric B. Mosbrooker | M | 46 | 3 años | |
| Derek DiRocco | M | 43 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 4 años |
| Sanj Patel | M | 54 | 9 años | |
| John W. Wallen | M | 66 | 12 años | |
| Kathleen Gallagher | F | - | 3 años | |
| Arthur Levin | M | 70 | 11 años | |
| Rod Wong | M | 47 | 6 años | |
| Mark Ragosa | M | 50 | 6 años | |
| Sarah Boyce | F | 52 | 5 años | |
| Michael Megna | M | 53 | 6 años | |
| Kinnari Patel | M | 45 | 6 años | |
| Jonathan Schwartz | M | 60 | 8 años | |
| R. Woods | M | 56 | 1 años | |
| Melissa Manno | F | - | 9 años | |
| Martin Wilson | M | 47 | 3 años | |
| Gayatri R. Rao | M | - | 6 años | |
| Sergio Quezada | M | 49 | 4 años | |
| Tracey McCain | F | 56 | 6 años | |
| Tamar Thompson | F | 50 | 3 años | |
| Daniel Hood | M | - | - | |
| Felix Baker | M | 55 | 9 años | |
| Noreen Henig | M | 59 | 5 años | |
| Mark White | M | 57 | 1 años | |
| Bernhard R. M. Ehmer | M | 69 | 2 años | |
| Pedro Granadillo | M | 77 | 6 años | |
| Richard Levy | M | 66 | 5 años | |
| Kim Popovits | F | 65 | 6 años | |
| Naveen Yalamanchi | M | 47 | 6 años | |
| Jean Kim | F | 50 | 3 años | |
| Michael MacLean | M | 58 | 4 años | |
| Edward Kaye | M | 75 | 5 años | |
| Gotham Makker | M | 52 | 6 años | |
| Henrik Ehlers Wulff | M | 54 | 25 años | |
| Karsten Munk Knudsen | M | 53 | 25 años | |
| Fady Malik | M | 60 | 2 años | |
| Simona Skerjanec | F | 59 | - | |
| Margareta Elisabeth Björk | M | 62 | 4 años | |
| Thomas Malley | M | 55 | 8 años | |
| Edward Samuel | M | - | 2 años | |
| Liz Elmhirst | F | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| James Taylor | M | - | 2 años | |
| Tariq Ahmed | M | - | 4 años | |
| Shree Patel | M | - | - | |
| Carlos Martin | M | - | - | |
| Kevin Giordano | M | - | 3 años | |
| Robert Coutts | M | 40 | 4 años | |
| Brooks Rahmer | M | - | - | |
| Ross Moat | M | 43 | 5 años | |
| Dara Henry | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Martin Lange | M | 54 | 22 años | |
| Martina Struck | M | - | 6 años | |
| Rogier Rooswinkel | M | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
| Steven G. Hughes | M | 57 | 2 años | |
| Camilla Sylvest | F | 52 | 28 años | |
| Maziar Mike Doustdar | M | 54 | 32 años | |
| Elisa Petris | M | 45 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | 8 años |
| John Paolini | M | 59 | 8 años | |
| Martin Murphy | M | 55 |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Christopher Heberlig | M | 49 | 12 años | |
| Thomas Beetham | M | 55 | 8 años | |
| Stephen Mahoney | M | 53 | 7 años | |
| Brian Batchelder | M | - | - | |
| Mayur Kasetty | M | - | 4 años | |
| Rasmus Holm-Jorgensen | M | 53 | 11 años | |
| Jakob Riis | M | 58 | 21 años | |
| Todd Brady | M | 45 | 5 años | |
| Deirdre O’Donnell | F | - | - | |
| Brendan Classon | M | - | - | |
| Allison Dorval | F | 48 | 7 años | |
| Michael Martin | M | 50 | 5 años | |
| Lynn A. Taylor | F | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Mark Goldberg | M | 69 | 6 años | |
| Thomas Tisch | M | 69 | 3 años | |
| Steven T. Sobieski | M | 66 | 10 años | |
| Joseph Zakrzewski | M | 60 | 9 años | |
| John T. Garibotto | M | 59 | 8 años | |
| Mads Krogsgaard Thomsen | M | 63 | 30 años | |
| Jesper Brandgaard | M | 60 | 20 años | |
| Sten Scheibye | M | 72 | 10 años | |
| Kurt Anker Nielsen | M | 78 | 13 años | |
| Stephen Davis | M | 63 | 4 años | |
| Harry Penner | M | 78 | 8 años | |
| Peter Wirth | M | 73 | 3 años | |
| Sally Crawford | F | 70 | 13 años | |
| Lars Robert Boesgaard | M | 55 | 5 años | |
| Larry L. Mathis | M | 80 | 10 años | |
| Regina Sommer | F | 66 | 9 años | |
| Carsten Hellmann | M | 60 | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 69 | 69.00% |
| Reino Unido | 18 | 18.00% |
| Dinamarca | 13 | 13.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Carsten Boess
- Red Personal
